At the same time, flexibility has become the lynchpin of a well-traveled myth that corporations have spun to their employees, policymakers, and the public. While this myth doesn’t survive close ...
OSLO, Norway, June 8, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The ...
Morning Overview on MSN
A prostate cancer drug halved the odds of the disease spreading
Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results